| Hans-Günter Meyer-Thompson | International
SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk
SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk
This Advisory examines the role of genetic testing in assessing SUD vulnerability and outlines the current limitations of these technologies.
Publication ID PEP24-02-014, Publication Date December 2024
https://store.samhsa.gov/sites/default/files/genetic-testing-sud-risk-pep24-02-014.pdf